FDA — authorised 30 August 2019
- Application: ANDA203166
- Marketing authorisation holder: LGM PHARMA
- Status: supplemented
🇺🇸 Relafen in United States
FDA authorised Relafen on 30 August 2019
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Relafen approved in United States?
Yes. FDA authorised it on 30 August 2019; FDA has authorised it.
Who is the marketing authorisation holder for Relafen in United States?
LGM PHARMA holds the US marketing authorisation.